Calithera Biosciences, Inc. (NASDAQ:CALA – Get Free Report)’s stock price passed below its two hundred day moving average during trading on Wednesday . The stock has a two hundred day moving average of $0.01 and traded as low as $0.00. Calithera Biosciences shares last traded at $0.00, with a volume of 473 shares trading hands.
Analysts Set New Price Targets
Separately, StockNews.com assumed coverage on Calithera Biosciences in a report on Thursday. They issued a “hold” rating for the company.
View Our Latest Stock Analysis on CALA
Calithera Biosciences Trading Down 90.0 %
About Calithera Biosciences
Calithera Biosciences, Inc operates under a plan of liquidation that was approved in January 2023. Previously, the company was engaged in the clinical stage precision oncology biopharmaceutical business. Calithera Biosciences, Inc was incorporated in 2010 and is headquartered in South San Francisco, California.
See Also
- Five stocks we like better than Calithera Biosciences
- What is Insider Trading? What You Can Learn from Insider Trading
- Hedge Funds Boost Oil Positions: Is a Major Rally on the Horizon?
- What is the S&P/TSX Index?
- Power Play: Japan’s Top Auto Stocks Eye Historic Merger
- Comparing and Trading High PE Ratio Stocks
- S&P 500 Earnings Set to Shine: January’s Critical Market Test
Receive News & Ratings for Calithera Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Calithera Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.
